Compare Dollar General Corp. (DG) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dollar General Corp. vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Dollar General Corp. trades at $127.23 (market cap $27.42B), while Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B). The key difference: Dollar General Corp. is far larger — about 2.2× Halozyme Therapeutics Inc. Common Stock's market cap, and Dollar General Corp. pays a 1.9% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dollar General Corp. for 59 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| DG | HALO | |
|---|---|---|
Market Cap | $27.42B | $12.58B |
Volume | 2,291,517 | 2,179,278 |
Sector | Consumer Staples | Health |
52-Week High | $156.26 | $115.22 |
52-Week Low | $95.94 | $61.63 |
Typical Hold Time | 59 Days | 1 Days |
Enterprise Value | $41.60B | $14.49B |
Dividend Yield | 1.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dollar General (DG) trades at $124.27, up 1.73% today, with a bullish technical signal from moving averages and strong analyst support (55.77% buy ratings). Recent quarters show consistent earnings beats, with Q2 2026 EPS of $2.48 exceeding the $2.01 estimate. The company benefits from tariff refunds boosting margins and is expanding delivery via Instacart and scaling its DG Media Network for growth.
The outlook is positive, with a consensus price target of $137.27 implying ~10% upside. Key opportunities include margin recovery initiatives and value-focused merchandising, but risks persist from consumer pressure and competitive discount retail dynamics. Net cash flow improved to $395 million in 2025, though profit margins have narrowed from 7.01% in 2022 to 2.77% in 2025.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Dollar General Corp.
A leading American discount retailer, Dollar General operates over 18,000 stores in 47 states, selling branded and private-label products across a wide variety of categories. In fiscal 2021, 77% of net sales came from consumables (including paper and cleaning products, packaged and perishable food, tobacco, and health and beauty items), 12% from seasonal merchandise (such as toys, greeting cards, decorations, and gardening supplies), 7% from home products (for example, kitchen supplies, small appliances, and cookware), and 4% from basic apparel. Stores average roughly 7,400 square feet, and about 75% of Dollar General locations are in towns of 20,000 or fewer people. The firm emphasizes value, with most of its items sold at everyday low prices of $5 or less.
Read more on DG →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
